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OBJECTIVE — To evaluate metabolic syndrome and cardiovascular disease risk factors in
prepubertal children born large for gestational age (LGA) to nondiabetic, nonobese mothers.
RESEARCH DESIGN AND METHODS — At 6–7 years of age, the comparison of
various factors was made between 31 LGA and 34 appropriate-for-gestational-age (AGA)
children:ﬁbrinogen,antithrombinIII,proteinCandS,fastinginsulin,glucose,homeostasis
assessment model of insulin resistance (HOMA-IR) index, adiponectin, leptin, visfatin,
IGF-1, IGF-binding protein (IGFBP)-1, IGFBP-3, lipids, and the genetic factors V Leiden
G1691A mutation, prothrombin 20210A/G polymorphism, and mutation in the enzyme
5,10-methylenetetrahydrofolate-reductase gene (MTHFR-C677T).
RESULTS — LGA children had higher levels of leptin (P  0.01), fasting insulin (P  0.01),
and HOMA-IR (P  0.01), but lower IGFBP-3 (P  0.0001), ﬁbrinogen (P  0.0001), and
lipoprotein(a) (P  0.001) than AGA children. Signiﬁcantly more LGA children were homozy-
gous for the MTHFR-C677T mutation (P  0.0016).
CONCLUSIONS — Being born LGA to nondiabetic, nonobese mothers is associated with
diverse effects on cardiometabolic risk factors at prepuberty.
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L
arge-for-gestational-age (LGA) in-
fants may be at risk for the devel-
opment of obesity and insulin
resistance (1–4). A relationship between
excess birth weight and metabolic syn-
drome (MetS) and cardiovascular disease
(CVD) risk factors (1–4) has not yet been
clearly demonstrated.
The aim of this study was to evaluate
markers of the prothrombotic state and
other MetS and CVD risk factors in pre-
pubertal children born LGA to nondia-
betic, nonobese mothers.
RESEARCH DESIGN AND
METHODS— The study group con-
sisted of 64 singleton Caucasian children,
born at term: 31 (10 female, 21 male) were
LGA(birthweight95thpercentileforges-
tational age), and 33 (12 female, 21 male)
appropriateforgestationalage(AGA)(birth
weight 10th–90th percentile). No mother
wasobese(pregestationalBMI30kg/m
2),
and all had a normal glucose challenge test
during pregnancy.
The children were examined at 6–7
years of age, at which time all were prepu-
bertal. The data compared were: obesity in-
dexes [waist circumference, body weight,
and BMI]; arterial blood pressure (BP) ex-
pressed as z scores; blood levels of ﬁbrino-
gen, antithrombin III, protein C and S,
lipoprotein(a) [Lp(a)], adiponectin, leptin,
visfatin, IGF-1, IGF-binding protein
(IGFBP)-1,IGFBP-3,fastinginsulin(IF)and
glucose (GF) levels, the homeostasis assess-
ment model of insulin resistance (HOMA-
IR) index, the lipid proﬁle, and the genetic
factors V Leiden G1691A mutation, pro-
thrombin 20210A/G polymorphism, and
mutationintheenzyme5,10-methylenetet-
rahydrofolate-reductase gene (MTHFR-
C677T). Venous blood samples were
drawn from the children after a 12-h over-
night fast. Written informed parental con-
sent was obtained for the participation of
each child, and the study was approved by
the local research ethics committee.
Components of the IGFs-axis, leptin,
and adiponectin levels were measured by
ELISA. Serum visfatin COOH-terminal
levels were determined by a competitive
enzyme immunoassay (Phoenix Pharma-
ceuticals). Coagulation assessment was
determined using functional methods
and chromatometric assays. Genomic
DNA was isolated from the leukocytes of
peripheral whole-blood samples col-
lected in EDTA-anticoagulant according
to standard methods (5). Lipids and IF
and GF levels were determined with tech-
niques previously described (1).
Data were analyzed by ANOVA and
multiple regression analysis using the
StatView software package of SAS Insti-
tute (Cary, NC).
RESULTS— The anthropometric and
laboratory ﬁndings are depicted in Table
1. The signiﬁcant differences in leptin, IF,
and HOMA-IR between LGA and AGA
children persisted after controlling for
age, sex, and BMI.
Homozygocity for the MTHFR-
C677T mutation was detected in 12
LGA and 2 AGA children (P  0.002)
and heterozygocity in 19 LGA and 8
AGA children (P  0.003). Three LGA
and none of the AGA children were het-
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tion (P  0.06). One LGA but no AGA
child was heterozygous for the Factor V
Leiden (FVL) G1691A mutation. No
child was homozygous for the pro-
thrombin (PT) G20210A mutation or
FVL polymorphism.
Correlation studies
On pooled data for LGA and AGA chil-
dren, multiple regression analysis re-
vealed negative correlation between birth
weight z score and ﬁbrinogen level (t 
3.8, P  0.01), Lp(a) level (t  3.4,
P  0.01), and IGFBP-3 level (t  2.5,
P  0.01), and positive correlation be-
tween birth weight z score and IF level
(t  2.8, P  0.01) and HOMA-IR (t 
2.9, P  0.001), independent of BMI or
waist circumference z score.
Incidence of components of the MetS
and other CVD risk factors
Of the LGA group, 9.7% fulﬁlled the cri-
teria for MetS (3 components: waist cir-
cumference 90th percentile for age and
sexforGreekchildren;BP95thpercentile
for age, sex, and height; GF 100 mg/dl;
triglycerides 95th percentile; and HDL
5th percentile) (6,7), while no AGA
child presented three components. In
the AGA group, 54.5% of the children
were completely free of components of
MetS or risk factors for CVD (BP 90th
percentile, IF 15 U/ml, fasting glu-
cose-to-insulin ratio 7, HOMA-IR
2.83, or BMI 85th percentile) (6,8),
while only 22.6% of the LGA children
were free of components or risk factors
(P  0.008).
CONCLUSIONS— Children born
LGA at term to nondiabetic, nonobese
mothers are at signiﬁcant risk of develop-
ing MetS. Diverse effects on CVD risk fac-
tors were observed in this group.
LGAchildrenhadsigniﬁcantlyhigher
indexes of insulin resistance (IF and
HOMA-IR), independent of BMI or waist
circumference z scores. The higher in-
dexes of obesity, such as BMI and waist
circumferencefoundinthisgroupmaybe
attributed to earlier adiposity rebound
(4,9).
Increase in ﬁbrinogen level is associ-
ated with both chronic inﬂammation and
insulin resistance in adults with MetS.
LGA children had a signiﬁcantly lower
level of ﬁbrinogen than AGA children.
The negative association between ﬁbrino-
gen level and birth weight suggests that
excess intrauterine growth may signiﬁ-
cantly affect this factor in a direction dif-
ferent from the other factors contributing
to CVD and MetS, and there is evidence
that genetic factors may account for the
negativeassociation(10,11).Ageneticin-
ﬂuence may also be responsible for the
lower levels of Lp(a) found in the LGA
group.
The nature of the association found
between LGA and mutation C677T in the
MTHFR gene is unexplained and of un-
known signiﬁcance. This mutation is as-
sociated in the homozygous state with
decreased speciﬁc MTHFR activity and
elevation in homocysteine levels, which
hasbeenidentiﬁedasanindependentrisk
factor for myocardial infarction and mor-
tality in patients with conﬁrmed CVD
(12). The signiﬁcantly higher rate of ho-
mozygosityfortheMTHFR-C677Tmuta-
tionintheLGAgroupindicatesapossible
risk for hyperhomocysteinemia, which
warrants further investigation. The inde-
pendent negative relationship observed
between IGFBP-3 and birth weight may
imply a possible inﬂuence of excess intra-
uterine growth on IGFBP-3 level at pre-
puberty. Reduced plasma IGF-1 level is
considered to reﬂect a higher risk for in-
sulin resistance and CVD (13). In the
present study, although LGA children
had higher insulin resistance indexes,
they also showed a trend toward higher
IGF-1 levels. This may indicate a possible
protective mechanism against develop-
ment of insulin resistance (13).
In summary, diverse effects on CVD
risk factors were observed in term LGA
children at prepuberty. They had higher
insulin resistance indexes and anthropo-
metric obesity markers, but lower ﬁbrin-
ogen and Lp(a) levels than matched AGA
children. They also had a higher preva-
lence of the MTHFR-C677T mutation.
LGA offspring of nondiabetic, nonobese
mothers warrant careful monitoring for
evidence of MetS precursors throughout
childhood and beyond.
Table 1—Characteristics, anthropometric indices, and indices of the prothrombotic state and
insulin resistance, components of the IGFs-axis, lipid proﬁle, and adipocytokines (means  SD)
at prepuberty of children born LGA (birth weight >95th percentile) or AGA (birth weight
10th–90th percentile)
Characteristics and parameters LGA group AGA group P value
n 31 33 —
Age (years) 6.5  0.5 6.4  0.6 ns
Body weight (kg) 32  82 4  6 0.01
Body height (cm) 126  8 119  9 0.08
Waist circumference z score 0.80  0.98 0.06  1.3 0.05
BMI z score 0.80  0.80 0.20  0.8 0.001
Systolic BP z score 0.49  0.41 0.41  0.43 ns
Diastolic BP z score 0.71  0.35 0.51  0.5 ns
Prothrombin time (s) 13.29  0.53 13.2  0.52 ns
APTT (s) 37.04  22 38.64  24 ns
Fibrinogen (mol/l) 7.67  0.9 10.05  2.3 0.0001
Antithrombin III (%) 104  50 107  69 ns
Protein C (%) 99  11 97  18 ns
Protein S (%) 69  24 70  19 ns
Fasting glucose (mmol/l) 5.1  0.5 4.9  0.6 ns
Fasting insulin (pmol/l) 48.6  20.1 27  24.3 0.01
FGIR 0.11  0.05 0.25  0.11 0.0001
HOMA-IR 1.5  0.6 0.8  0.7 0.01
IGF-1 (g/l) 189  115 140  84 0.06
IGFBP-1 (g/l) 84  33 88  31 ns
IGFBP-3 (mg/l) 2.6  1.1 3.9  0.8 0.0001
t cholesterol (mmol/l) 4.53  0.6 4.45  0.6 ns
HDL (mmol/l) 1.41  0.2 1.45  0.2 ns
Triglycerides (mmol/l) 0.65  0.1 0.71  0.2 ns
Lipoprotein(a) (mol/l) 0.09  0.1 0.3  0.2 0.001
Adiponectin (mg/l) 16.3  6 14.7  5n s
Leptin (g/l) 52  23 31  19 0.01
Visfatin (g/l) 13.3  61 3  5n s
APTT,activatedpartialthromboplastintime;FGIR,fastingglucose-to-insulinratio;ns,notsigniﬁcant(P0.05).
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